Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)
type: MedicalStudy
description: A Phase III Clinical Trial to Demonstrate Efficacy / Safety of Liposomal Cyclosporine A + Standard of Care (SoC) vs SoC Alone in Treating Chronic Lung Allograft Dysfunction / Bronchiolitis Obliterans in Patients Post Double Lung Transplant
status: COMPLETED
study design: INTERVENTIONAL
phase: PHASE3
start date: 2019-03-26
end date: 2024-03-12
license: https://creativecommons.org/publicdomain/zero/1.0/
source: https://clinicaltrials.gov/study/NCT03656926
source organization: US National Library of Medicine
publisher: AI Analytics
sponsor: Zambon SpA
study subject: Bronchiolitis Obliterans
study subject: Chronic Rejection of Lung Transplant
study subject: Lung Transplant Rejection
study subject: Lung Transplant; Complications
study subject: Lung Transplant Failure and Rejection
study subject: Chronic Lung Allograft Dysfunction
keywords: PHASE3
keywords: INTERVENTIONAL
keywords: COMPLETED
keywords: Bronchiolitis Obliterans
keywords: Chronic Rejection of Lung Transplant
keywords: Lung Transplant Rejection
keywords: Lung Transplant; Complications
keywords: Lung Transplant Failure and Rejection

AI Analytics
type: Organization